Mesothelioma Clinical Trials Resume After COVID-19 Disruption

When the COVID-19 pandemic struck earlier this year, clinical trials at medical centers around the world slowed enrollment or placed trial activities on hold. As businesses begin to reopen in the United States, more treatment centers are resuming mesothelioma study activities and ramping up enrollment. Clinical research trials offer patients access to experimental mesothelioma treatments that haven’t yet been approved by the U.S. Food and Drug Administration. These treatments may provide higher chances of survival than the current standard of care. “So far, every patient I have seen during the COVID-19 pandemic has favored alternative therapies to surgery,” Dr. Nestor Villamizar, a thoracic surgeon at Sylvester Comprehensive Care Center in Miami, told The Mesothelioma Center at Asbestos.com. “These are showing promising results, like dual immunotherapy and chemotherapy with Tumor Treating Fields.” A number of treatment centers, such as Brigham and Women’s Hospital in Boston, delayed mesothelioma clinical trials at the start of the pandemic. Others, such as the Pacific Mesothelioma Center in Los Angeles, continued screening patients, but on a limited basis. Now, many mesothelioma clinical trials are resuming regular screening and enrollment measures for mesothelioma patients at most sites. Hundreds of Cancer Clinical Trials Now Back on Course Thanks to measures put in place by the National Cancer Institute, medical professionals have b...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news

Related Links:

For the sixth consecutive year, University of Texas MD Anderson Cancer Center in Houston was named the top Adult Cancer Hospital in America by U.S. News &World Report. Several of the top-tier cancer centers on the list have specialty programs for mesothelioma that contributed to their high ranking. The 2020-21 Best Hospitals for Cancer rankings, announced this week, are part of a broader Best Hospitals Honor Roll done annually by U.S. News &World Report. Top five cancer center rankings also included Memorial Sloan Kettering in New York City; Mayo Clinic in Rochester, Minnesota; Johns Hopkins Hospital in Baltimore a...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
For the sixth consecutive year, University of Texas MD Anderson Cancer Center in Houston was named the top Adult Cancer Hospital in America by U.S. News &World Report. Several of the top-tier cancer centers on the list have specialty programs for mesothelioma that contributed to their high ranking. The 2020-21 Best Hospitals for Cancer rankings, announced this week, are part of a broader Best Hospitals Honor Roll done annually by U.S. News &World Report. Top five cancer center rankings also included Memorial Sloan Kettering in New York City; Mayo Clinic in Rochester, Minnesota; Johns Hopkins Hospital in Baltimore a...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
The COVID-19 pandemic closed educational institutions everywhere, but it also opened a door to the acceleration of vitally important asbestos abatement in schools where children would have been in attendance. Business has been booming. “It does look like a lot of schools took advantage of it [the closing of facilities],” Brent Kynoch, managing director of the Environmental Information Association, told The Mesothelioma Center at Asbestos.com. “They may have had work contracted for later in the summer, but just said, ‘Let’s get started with it now, and get it done.’ They understood the im...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Doctors, scientists and occupational health experts from across the country are openly criticizing the U.S. Environmental Protection Agency’s recent asbestos draft risk evaluation. At a virtual press conference arranged by the Asbestos Disease Awareness Organization last week, speakers labeled the asbestos evaluation inadequate and in need of serious revision. The year-long evaluation was required as part of the Frank R. Lautenberg Chemical Safety for the 21st Century Act, which was passed in 2016. It amended the original Toxic Substances Control Act, the country’s primary chemicals management law. “I am...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
An international, much-anticipated phase III clinical trial that could change standard-of-care treatment for patients with malignant pleural mesothelioma will open soon, pending COVID-19 pandemic restrictions. The randomized trial will be studying the effectiveness of the immunotherapy drug durvalumab (Imfinzi) when used in combination with chemotherapy drugs pemetrexed (Alimta) and cisplatin for mesothelioma. Opening dates may vary by center because of the COVID-19 pandemic that has slowed or stalled clinical trials everywhere. Durvalumab produces an antibody that helps a patient’s own immune system kill tumor cell...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Johnson &Johnson announced Tuesday that it will stop selling its iconic, talc-based baby powder, the target of thousands of lawsuits claiming that its talc was contaminated with asbestos, which led to cancers such as mesothelioma and ovarian cancer. The company said the stoppage is only in the United States and Canada, citing a decline in consumer demand and “misinformation” about the safety of the product. “Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product ...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
No town in America has a higher percentage of asbestos-related lung disease — and resulting respiratory issues — than Libby, Montana, making its population uniquely vulnerable to the COVID-19 pandemic. Yet no town has responded to the threat so effectively. The home of the longest-running man-made environmental disaster in U.S. history — the mining of toxic asbestos for 70 years — has refused to let COVID-19 dictate who lives and who dies. The Center for Asbestos Related Disease, also known as CARD, has stepped up and taken charge. “We can’t afford to let the virus get loose here because...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
The U.S. Environmental Protection Agency postponed indefinitely a peer review of the recent asbestos risk evaluation draft done by its Science Advisory Committee on Chemicals. A peer review virtual meeting was scheduled for April 27-30, but several independent scientific experts on the panel are no longer available. A Bloomberg Law article published this week explained that several health professionals serving on the committee could not attend because they needed to “give their full attention to the coronavirus crisis.” No date for the rescheduling was announced. “The agency believes that rescheduling for...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Medical centers across the country have slowed or stopped the enrollment of new patients in mesothelioma clinical trials because of the all-consuming COVID-19 pandemic. The pause in enrollment options could be critical for newly diagnosed patients with pleural mesothelioma, whose life expectancy is often just six to 12 months. Clinical trials are research studies where patients can find cutting-edge treatments not yet approved by the U.S. Food and Drug Administration. Those experimental treatments go beyond standard of care, which generally has not been effective for this rare and aggressive cancer caused by asbestos expos...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
As the U.S. comes to grips with the challenges of the COVID-19 pandemic, mesothelioma cancer survivors face additional hurdles, including difficulty receiving care. Patients currently undergoing treatment for cancer and those who are immunocompromised are at greater risk of serious health issues if they contract COVID-19, according to the Centers for Disease Control and Prevention. “Cancer patients are a high-risk group and should be extra vigilant in terms of isolation precautions. They should follow the medical authorities’ instructions,” Dr. Ory Wiesel, a thoracic surgeon at Maimonides Medical Center ...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
More News: Alternative and Complementary Therapies | Asbestosis | Cancer | Cancer & Oncology | Cardiology | Cardiovascular & Thoracic Surgery | Chemotherapy | Clinical Trials | Complementary Medicine | Contracts | COVID-19 | Environmental Health | Food and Drug Administration (FDA) | Heart | Hospitals | Immunotherapy | Mesothelioma | Pandemics | Study | USA Health | Women